SEC Form 4 · accession 0001209191-17-001579
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Markus J. Cappel
Officer — Chief Bus. Officer & Treasurer
Period of report
Jan 1, 2017
Accepted (ET)
Jan 4, 2017 · 8:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 1, 2017 | M | 8,333 | $0.00 | A | 20,833 | D | |
| Common StockF2 | Jan 1, 2017 | F | 4,442 | $7.40 | D | 16,391 | D | |
| Common Stock | Jan 3, 2017 | M | 26,821 | $4.30 | A | 43,212 | D | |
| Common StockF4,F5 | Jan 3, 2017 | S | 26,821 | $7.5055 | D | 16,391 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF6,F7 | — | Jan 1, 2017 | M | 8,333 | D | — | — | Common Stock | 8,333 | 16,667 | D |
| Stock Option (right to buy)F9,F8 | $4.30 | Jan 3, 2017 | M | 26,821 | D | Feb 6, 2007 | Feb 6, 2017 | Common Stock | 26,821 | 0 | D |
Explanation of responses
- F1Shares were acquired upon vesting of restricted stock units awarded on March 7, 2016.
- F2Represents shares withheld upon vesting of restricted stock units to satisfy tax withholding obligation.
- F3The sales reported in this Form 4 were effected pursuant to a June 2016 Rule 10b5-1 trading plan adopted by the Reporting Person.
- F4Shares sold are associated with stock options which will expire in February 2017.
- F5Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.50 to $7.59 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- F6Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
- F7The restricted stock units vest in three equal installments on January 1, 2017, January 1, 2018, and January 1, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer through each such vesting date. Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.
- F8As of January 3, 2017, and prior to this transaction, the option fully vested.
- F9Not applicable.